The impact of direct‐acting anti‐virals on the hepatitis C care cascade: identifying progress and gaps towards hepatitis C elimination in the United States

Summary Background The hepatitis C virus (HCV) care cascade has changed dramatically following the introduction of direct‐acting anti‐virals (DAAs). Up‐to‐date estimates of the cascade are needed to monitor progress, identify key gaps and inform policy. Aim To estimate the current and future HCV care cascade in the United States, nationally and in select subpopulations of interest. Methods We used a previously validated mathematical model to...